Quantcast

Entelos Releases Commercial Dog Nutrition Simulation Model

July 30, 2013

New physiological model provides platform for petfood manufacturers to better predict the nutritional effects of their products.

San Mateo, California (PRWEB) July 31, 2013

Entelos, a premier provider of physiological system modeling and services that help pharmaceutical and consumer product companies predict better paths to success, today announced the availability of a new commercial quantitative physiological model that will enable petfood manufacturers to predict the effects of different diets on dogs and replace expensive and lengthy animal testing.

“The petfood market is a $59 billion industry that is extremely competitive and requires manufacturers to deliver better scientifically proven nutrition at lower costs,” said Entelos President and CEO, Shawn O’Connor. “Our transformational simulation approach provides the foundation for petfood R&D groups to run quick and humane computer simulations for different diets on different dog types."

The new Dog Nutrition PhysioLab is a mathematical physiological model designed to simulate, examine and explore the effects of food intake within dog diets and the corresponding body weight outcomes. The model provides a foundation to investigate effects of macronutrient intake relative to exercise, age and size simulating carbohydrate, protein and triglyceride mass balance to determine total body mass and total fat. The model includes the simulation and quantitative insights into the canine circulatory system, adipose tissue, liver, muscle and GI tract. Additionally, simulations take into consideration the hormonal control from hormones such as glucagon, insulin, epinephrine, adiponectin and other gastrointestinal hormones on weight loss and gain.

About Entelos

Entelos is an in silico modeling and simulation software and services company delivering predictive technologies reducing risk, time, and cost of product development for pharmaceutical, biotechnology, nutrition and consumer products customers. The Company's PhysioLab systems biology platforms generate virtual populations providing highly predictive analyses to develop safer and more effective drugs, foods and consumer products and help eliminate the need for animal testing. Entelos’ understanding of consumer variability has significant application to the emerging field of personalized medicine and products. The Company is headquartered in San Mateo, California. For more information, please visit http://www.entelos.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10952719.htm


Source: prweb



comments powered by Disqus